Protocol for cost-effectiveness analysis of a randomised trial of mHealth coaching (Bump2Baby and Me) compared with usual care for healthy gestational weight gain and postnatal outcomes in at-risk women and their offspring in the UK, Australia, Ireland and Spain.

Nørmark, LP McAuliffe, F Maindal, HT O'Reilly, S Davies, A Burden, C Skinner, TC Vrangbæk, K Callander, E

Copyright Clearance Process

• Recently Added
• In Progress
• Open Access

This item is open access.

Adobe PDF

Download Published versionAdobe PDF (328.89 kB)

View on publisher's site

View statistics

Full metadata record

Field	Value	Language
dc.contributor.author	Nørmark, LP
dc.contributor.author	McAuliffe, F
dc.contributor.author	Maindal, HT
dc.contributor.author	O'Reilly, S
dc.contributor.author	Davies, A
dc.contributor.author	Burden, C
dc.contributor.author	Skinner, TC
dc.contributor.author	Vrangbæk, K
dc.contributor.author	Callander, E https://orcid.org/0000-0001-7233-6804
dc.date.accessioned	2024-08-06T03:39:55Z
dc.date.available	2024-05-03
dc.date.available	2024-08-06T03:39:55Z
dc.date.issued	2024-05-21
dc.identifier.citation	BMJ Open, 2024, 14, (5), pp. e080823
dc.identifier.issn	2044-6055
dc.identifier.issn	2044-6055
dc.identifier.uri	http://hdl.handle.net/10453/180147
dc.description.abstract	INTRODUCTION: Gestational diabetes mellitus and overweight are associated with an increased likelihood of complications during birth and for the newborn baby. These complications lead to increased immediate and long-term healthcare costs as well as reduced health and well-being in women and infants. This protocol presents the health economic evaluation to investigate the cost-effectiveness of Bump2Baby and Me (B2B&Me), which is a health coaching intervention delivered via smartphone to women at risk of gestational diabetes. METHODS AND ANALYSIS: Using data from the B2B&Me randomised controlled trial, this economic evaluation compares costs and health effects between the intervention and control group as an incremental cost-effectiveness ratio. Direct healthcare costs, costs of pharmaceuticals and intervention costs will be included in the analysis, body weight and quality-adjusted life-years for the mother will serve as the effect outcomes. To investigate the long-term cost-effectiveness of the trial, a Markov model will be employed. Deterministic and probabilistic sensitivity analysis will be employed. ETHICS AND DISSEMINATION: The National Maternity Hospital Human Research and Ethics Committee was the primary approval site (EC18.2020) with approvals from University College Dublin HREC-Sciences (LS-E-20-150-OReilly), Junta de Andalucia CEIM/CEI Provincial de Granada (2087-M1-22), Monash Health HREC (RES-20-0000-892A) and National Health Service Health Research Authority and Health and Care Research Wales (HCRW) (21/WA/0022). The results from the analysis will be disseminated in scientific papers, through conference presentations and through different channels for communication within the project. TRIAL REGISTRATION NUMBER: ACTRN12620001240932.
dc.format	Electronic
dc.language	eng
dc.publisher	BMJ
dc.relation.ispartof	BMJ Open
dc.relation.isbasedon	10.1136/bmjopen-2023-080823
dc.rights	info:eu-repo/semantics/openAccess
dc.subject	1103 Clinical Sciences, 1117 Public Health and Health Services, 1199 Other Medical and Health Sciences
dc.subject.classification	32 Biomedical and clinical sciences
dc.subject.classification	42 Health sciences
dc.subject.classification	52 Psychology
dc.subject.mesh	Humans
dc.subject.mesh	Cost-Benefit Analysis
dc.subject.mesh	Female
dc.subject.mesh	Pregnancy
dc.subject.mesh	Gestational Weight Gain
dc.subject.mesh	Telemedicine
dc.subject.mesh	Diabetes, Gestational
dc.subject.mesh	Infant, Newborn
dc.subject.mesh	Mentoring
dc.subject.mesh	Quality-Adjusted Life Years
dc.subject.mesh	Australia
dc.subject.mesh	Randomized Controlled Trials as Topic
dc.subject.mesh	United Kingdom
dc.subject.mesh	Ireland
dc.subject.mesh	Spain
dc.subject.mesh	Cost-Effectiveness Analysis
dc.subject.mesh	Humans
dc.subject.mesh	Diabetes, Gestational
dc.subject.mesh	Telemedicine
dc.subject.mesh	Pregnancy
dc.subject.mesh	Quality-Adjusted Life Years
dc.subject.mesh	Infant, Newborn
dc.subject.mesh	Cost-Benefit Analysis
dc.subject.mesh	Australia
dc.subject.mesh	Ireland
dc.subject.mesh	Spain
dc.subject.mesh	Female
dc.subject.mesh	Randomized Controlled Trials as Topic
dc.subject.mesh	United Kingdom
dc.subject.mesh	Mentoring
dc.subject.mesh	Gestational Weight Gain
dc.subject.mesh	Cost-Effectiveness Analysis
dc.subject.mesh	Humans
dc.subject.mesh	Cost-Benefit Analysis
dc.subject.mesh	Female
dc.subject.mesh	Pregnancy
dc.subject.mesh	Gestational Weight Gain
dc.subject.mesh	Telemedicine
dc.subject.mesh	Diabetes, Gestational
dc.subject.mesh	Infant, Newborn
dc.subject.mesh	Mentoring
dc.subject.mesh	Quality-Adjusted Life Years
dc.subject.mesh	Australia
dc.subject.mesh	Randomized Controlled Trials as Topic
dc.subject.mesh	United Kingdom
dc.subject.mesh	Ireland
dc.subject.mesh	Spain
dc.subject.mesh	Cost-Effectiveness Analysis
dc.title	Protocol for cost-effectiveness analysis of a randomised trial of mHealth coaching (Bump2Baby and Me) compared with usual care for healthy gestational weight gain and postnatal outcomes in at-risk women and their offspring in the UK, Australia, Ireland and Spain.
dc.type	Journal Article
utslib.citation.volume	14
utslib.location.activity	England
utslib.for	1103 Clinical Sciences
utslib.for	1117 Public Health and Health Services
utslib.for	1199 Other Medical and Health Sciences
pubs.organisational-group	University of Technology Sydney
pubs.organisational-group	University of Technology Sydney/Faculty of Health
utslib.copyright.status	open_access	*
dc.rights.license	This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0). To view a copy of this license, visit https://creativecommons.org/licenses/by-nc/4.0/
dc.date.updated	2024-08-06T03:39:54Z
pubs.issue	5
pubs.publication-status	Published online
pubs.volume	14
utslib.citation.issue	5